134 related articles for article (PubMed ID: 30414672)
1. Identification of a rare homozygous c.790C>T variation in the TFB2M gene in Korean patients with autism spectrum disorder.
Park CB; Choi VN; Jun JB; Kim JH; Lee Y; Lee J; Lim G; Kim J; Jeong SY; Yim SY
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):148-154. PubMed ID: 30414672
[TBL] [Abstract][Full Text] [Related]
2. Structural models of mammalian mitochondrial transcription factor B2.
Moustafa IM; Uchida A; Wang Y; Yennawar N; Cameron CE
Biochim Biophys Acta; 2015 Aug; 1849(8):987-1002. PubMed ID: 26066983
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of mitochondrial transcription factor B2 controls mitochondrial DNA binding and transcription.
Bostwick AM; Moya GE; Senti ML; Basu U; Shen J; Patel SS; Dittenhafer-Reed KE
Biochem Biophys Res Commun; 2020 Jul; 528(3):580-585. PubMed ID: 32505352
[TBL] [Abstract][Full Text] [Related]
4. Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.
Sánchez-Ferrero E; Coto E; Blázquez M; Ribacoba R; Guisasola LM; Salvador C; Alvarez V
Parkinsonism Relat Disord; 2009 Jul; 15(6):468-70. PubMed ID: 18980857
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription.
Watanabe A; Arai M; Koitabashi N; Niwano K; Ohyama Y; Yamada Y; Kato N; Kurabayashi M
Cardiovasc Res; 2011 Apr; 90(1):57-67. PubMed ID: 21113058
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial transcription factor B2 overexpression increases M2 macrophage infiltration via cytosolic mitochondrial DNA-stimulated Interleukin-6 secretion in ovarian cancer.
Wu W; Zhou S; Liu T; Liang D
Bioengineered; 2022 May; 13(5):12211-12223. PubMed ID: 35577351
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma.
Geng X; Geng Z; Li H; Zhang Y; Li J; Chang H
Liver Int; 2020 Jul; 40(7):1756-1769. PubMed ID: 32174027
[TBL] [Abstract][Full Text] [Related]
8. Genetic Evidence for Elevated Pathogenicity of Mitochondrial DNA Heteroplasmy in Autism Spectrum Disorder.
Wang Y; Picard M; Gu Z
PLoS Genet; 2016 Oct; 12(10):e1006391. PubMed ID: 27792786
[TBL] [Abstract][Full Text] [Related]
9. The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber's hereditary optic neuropathy-associated mitochondrial DNA mutation.
Jiang P; Jin X; Peng Y; Wang M; Liu H; Liu X; Zhang Z; Ji Y; Zhang J; Liang M; Zhao F; Sun YH; Zhang M; Zhou X; Chen Y; Mo JQ; Huang T; Qu J; Guan MX
Hum Mol Genet; 2016 Feb; 25(3):584-96. PubMed ID: 26647310
[TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing Identifies Novel De Novo Variants Interacting with Six Gene Networks in Autism Spectrum Disorder.
Kim N; Kim KH; Lim WJ; Kim J; Kim SA; Yoo HJ
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374967
[TBL] [Abstract][Full Text] [Related]
11. The C-terminal tails of the mitochondrial transcription factors Mtf1 and TFB2M are part of an autoinhibitory mechanism that regulates DNA binding.
Basu U; Mishra N; Farooqui M; Shen J; Johnson LC; Patel SS
J Biol Chem; 2020 May; 295(20):6823-6830. PubMed ID: 32241911
[TBL] [Abstract][Full Text] [Related]
12. TFB2M and POLRMT are essential for mammalian mitochondrial DNA replication.
Inatomi T; Matsuda S; Ishiuchi T; Do Y; Nakayama M; Abe S; Kasho K; Wanrooij S; Nakada K; Ichiyanagi K; Sasaki H; Yasukawa T; Kang D
Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119167. PubMed ID: 34744028
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas.
Correia RL; Oba-Shinjo SM; Uno M; Huang N; Marie SK
Mitochondrion; 2011 Jan; 11(1):48-53. PubMed ID: 20643228
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscapes of Chinese sporadic autism spectrum disorders revealed by whole-genome sequencing.
Wu J; Yu P; Jin X; Xu X; Li J; Li Z; Wang M; Wang T; Wu X; Jiang Y; Cai W; Mei J; Min Q; Xu Q; Zhou B; Guo H; Wang P; Zhou W; Hu Z; Li Y; Cai T; Wang Y; Xia K; Jiang YH; Sun ZS
J Genet Genomics; 2018 Oct; 45(10):527-538. PubMed ID: 30392784
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis of Mitochondrial Transcription Initiation.
Hillen HS; Morozov YI; Sarfallah A; Temiakov D; Cramer P
Cell; 2017 Nov; 171(5):1072-1081.e10. PubMed ID: 29149603
[TBL] [Abstract][Full Text] [Related]
16. A promoter variant in ZNF804A decreasing its expression increases the risk of autism spectrum disorder in the Han Chinese population.
Zhang L; Qin Y; Gong X; Peng R; Cai C; Zheng Y; Du Y; Wang H
Transl Psychiatry; 2019 Jan; 9(1):31. PubMed ID: 30670685
[TBL] [Abstract][Full Text] [Related]
17. Decreased Integrity, Content, and Increased Transcript Level of Mitochondrial DNA Are Associated with Keratoconus.
Hao XD; Chen ZL; Qu ML; Zhao XW; Li SX; Chen P
PLoS One; 2016; 11(10):e0165580. PubMed ID: 27783701
[TBL] [Abstract][Full Text] [Related]
18. Human Mitochondrial Transcription Factor B2 Is Required for Promoter Melting during Initiation of Transcription.
Posse V; Gustafsson CM
J Biol Chem; 2017 Feb; 292(7):2637-2645. PubMed ID: 28028173
[TBL] [Abstract][Full Text] [Related]
19. Novel rare missense variations and risk of autism spectrum disorder: whole-exome sequencing in two families with affected siblings and a two-stage follow-up study in a Japanese population.
Egawa J; Watanabe Y; Wang C; Inoue E; Sugimoto A; Sugiyama T; Igeta H; Nunokawa A; Shibuya M; Kushima I; Orime N; Hayashi T; Okada T; Uno Y; Ozaki N; Someya T
PLoS One; 2015; 10(3):e0119413. PubMed ID: 25806950
[TBL] [Abstract][Full Text] [Related]
20. Difference in mitochondrial DNA copy number in peripheral blood cells between probands with autism spectrum disorders and their unaffected siblings.
Yoo HJ; Park M; Kim SA
World J Biol Psychiatry; 2017 Mar; 18(2):151-156. PubMed ID: 27739340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
